An Open-label, Single-arm, Multi-centre, Long-term Extension Trial to Evaluate the Safety and Efficacy of Tralokinumab in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Clinical Trials
An Open-label, Single-arm, Multi-centre, Long-term Extension Trial to Evaluate the Safety and Efficacy of Tralokinumab in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Clinical Trials
The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.
Inclusion Criteria:
Exclusion Criteria:
Ostrava-Poruba, 708 52, Czechia
Ichikawa-shi, Chiba 272-0033, Japan
Ichikawa-shi, Chiba 272-0143, Japan
Nonoichi-shi, Ishikawa-ken 921-8801, Japan
Kawasaki-shi, Kanagawa 211-0063, Japan
Toyonaka-shi, Osaka 560-0085, Japan
Koto-Ku, Tokyo 136-0074, Japan
Minato-Ku, Tokyo 108-0014, Japan
Setagaya-ku, Tokyo 158-0097, Japan
Shinjuku-Ku, Tokyo 169-0075, Japan
Shimotsuke-shi, 329-0498, Japan